AndresAlejandroRedondoMD

Pulmonology • Miami, FL

Pleural Disease

Physician

Join to view full profile

Dr. Redondo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Redondo's full profile

Already have an account?

Office
3181 Sw 22 Street
2nd Floor
Miami, FL 33145
Phone+1 305-567-1999

Fax+1 305-567-9309
Is this information wrong?

Education & Training

St Barnabas HospitalResidency, Internal Medicine, 1983 - 1985
Pontificia Universidad Católica Madre y MaestraClass of 1982

Certifications & Licensure

FL State Medical License 1985 - 2026
IA State Medical License 1984 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Clinical Trials

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS Start of enrollment: 2009 Nov 01
Terminated
Phase 2
Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission Start of enrollment: 2010 Jun 01
Completed
Phase 2
Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Start of enrollment: 2014 Jun 01
Completed
Phase 2
Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. Start of enrollment: 2014 Jun 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

Lectures

Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persi...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Hospital Affiliations

Coral Gables HospitalMiami, Florida
HCA Florida Mercy HospitalMiami, Florida